A citation-based method for searching scientific literature

Christine P Diggle, Stacey J Sukoff Rizzo, Michael Popiolek, Reetta Hinttala, Jan-Philip Schülke, Manju A Kurian, Ian M Carr, Alexander F Markham, David T Bonthron, Christopher Watson, Saghira Malik Sharif, Veronica Reinhart, Larry C James, Michelle A Vanase-Frawley, Erik Charych, Melanie Allen, John Harms, Christopher J Schmidt, Joanne Ng, Karen Pysden, Christine Strick, Päivi Vieira, Katariina Mankinen, Hannaleena Kokkonen, Matti Kallioinen, Raija Sormunen, Juha O Rinne, Jarkko Johansson, Kati Alakurtti, Laura Huilaja, Tiina Hurskainen, Kaisa Tasanen, Eija Anttila, Tiago Reis Marques, Oliver Howes, Marius Politis, Somayyeh Fahiminiya, Khanh Q Nguyen, Jacek Majewski, Johanna Uusimaa, Eamonn Sheridan, Nicholas J Brandon. Am J Hum Genet 2016
Times Cited: 43







List of co-cited articles
465 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.
Niccolò E Mencacci, Erik-Jan Kamsteeg, Kosuke Nakashima, Lea R'Bibo, David S Lynch, Bettina Balint, Michèl A A P Willemsen, Matthew E Adams, Sarah Wiethoff, Kazunori Suzuki,[...]. Am J Hum Genet 2016
64
69

Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia.
Ying-Zhang Chen, Jennifer R Friedman, Dong-Hui Chen, Guy C-K Chan, Cinnamon S Bloss, Fuki M Hisama, Sarah E Topol, Andrew R Carson, Phillip H Pham, Emily S Bonkowski,[...]. Ann Neurol 2014
81
32

Phenotypic insights into ADCY5-associated disease.
Florence C F Chang, Ana Westenberger, Russell C Dale, Martin Smith, Hardev S Pall, Belen Perez-Dueñas, Padraic Grattan-Smith, Robert A Ouvrier, Neil Mahant, Bernadette C Hanna,[...]. Mov Disord 2016
75
30

ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations.
Dong-Hui Chen, Aurélie Méneret, Jennifer R Friedman, Olena Korvatska, Alona Gad, Emily S Bonkowski, Holly A Stessman, Diane Doummar, Cyril Mignot, Mathieu Anheim,[...]. Neurology 2015
74
27

ADCY5 mutations are another cause of benign hereditary chorea.
Niccolo E Mencacci, Roberto Erro, Sarah Wiethoff, Joshua Hersheson, Mina Ryten, Bettina Balint, Christos Ganos, Maria Stamelou, Niall Quinn, Henry Houlden,[...]. Neurology 2015
51
27

Phenotypic spectrum of GNAO1 variants: epileptic encephalopathy to involuntary movements with severe developmental delay.
Hirotomo Saitsu, Ryoko Fukai, Bruria Ben-Zeev, Yasunari Sakai, Masakazu Mimaki, Nobuhiko Okamoto, Yasuhiro Suzuki, Yukifumi Monden, Hiroshi Saito, Barak Tziperman,[...]. Eur J Hum Genet 2016
66
25

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.
Flavia Niccolini, Niccolo E Mencacci, Tayyabah Yousaf, Eugenii A Rabiner, Vincenzo Salpietro, Gennaro Pagano, Bettina Balint, Stephanie Efthymiou, Henry Houlden, Roger N Gunn,[...]. Mov Disord 2018
19
57

Mutations in GNAL cause primary torsion dystonia.
Tania Fuchs, Rachel Saunders-Pullman, Ikuo Masuho, Marta San Luciano, Deborah Raymond, Stewart Factor, Anthony E Lang, Tsao-Wei Liang, Richard M Trosch, Sierra White,[...]. Nat Genet 2013
196
23

Clinical Course of Six Children With GNAO1 Mutations Causing a Severe and Distinctive Movement Disorder.
Amitha L Ananth, Amy Robichaux-Viehoever, Young-Min Kim, Andrea Hanson-Kahn, Rachel Cox, Gregory M Enns, Jonathan Strober, Marcia Willing, Bradley L Schlaggar, Yvonne W Wu,[...]. Pediatr Neurol 2016
49
23

Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5.
Ying-Zhang Chen, Mark M Matsushita, Peggy Robertson, Mark Rieder, Santhosh Girirajan, Francesca Antonacci, Hillary Lipe, Evan E Eichler, Deborah A Nickerson, Thomas D Bird,[...]. Arch Neurol 2012
78
23

PET imaging shows loss of striatal PDE10A in patients with Huntington disease.
Rawaha Ahmad, Sophie Bourgeois, Andrey Postnov, Mark E Schmidt, Guy Bormans, Koen Van Laere, Wim Vandenberghe. Neurology 2014
54
23

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
Flavia Niccolini, Salman Haider, Tiago Reis Marques, Nils Muhlert, Andri C Tziortzi, Graham E Searle, Sridhar Natesan, Paola Piccini, Shitij Kapur, Eugenii A Rabiner,[...]. Brain 2015
62
23

Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species.
Timothy M Coskran, Daniel Morton, Frank S Menniti, Wendy O Adamowicz, Robin J Kleiman, Anne M Ryan, Christine A Strick, Christopher J Schmidt, Diane T Stephenson. J Histochem Cytochem 2006
199
23

A homozygous loss-of-function mutation in PDE2A associated to early-onset hereditary chorea.
Vincenzo Salpietro, Belen Perez-Dueñas, Kosuke Nakashima, Victoria San Antonio-Arce, Andreea Manole, Stephanie Efthymiou, Jana Vandrovcova, Conceicao Bettencourt, Niccolò E Mencacci, Christine Klein,[...]. Mov Disord 2018
24
41

Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum.
Akinori Nishi, Mahomi Kuroiwa, Diane B Miller, James P O'Callaghan, Helen S Bateup, Takahide Shuto, Naoki Sotogaku, Takaichi Fukuda, Nathaniel Heintz, Paul Greengard,[...]. J Neurosci 2008
192
20

Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging.
David S Russell, Danna L Jennings, Olivier Barret, Gilles D Tamagnan, Vincent M Carroll, Fabien Caillé, David Alagille, Thomas J Morley, Caroline Papin, John P Seibyl,[...]. Neurology 2016
44
20


Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Flavia Niccolini, Thomas Foltynie, Tiago Reis Marques, Nils Muhlert, Andri C Tziortzi, Graham E Searle, Sridhar Natesan, Shitij Kapur, Eugenii A Rabiner, Roger N Gunn,[...]. Brain 2015
72
20

ADCY5-related movement disorders: Frequency, disease course and phenotypic variability in a cohort of paediatric patients.
Miryam Carecchio, Niccolò E Mencacci, Alessandro Iodice, Roser Pons, Celeste Panteghini, Giovanna Zorzi, Federica Zibordi, Anastasios Bonakis, Argyris Dinopoulos, Joseph Jankovic,[...]. Parkinsonism Relat Disord 2017
44
20

Movement disorder in GNAO1 encephalopathy associated with gain-of-function mutations.
Huijie Feng, Benita Sjögren, Behirda Karaj, Vincent Shaw, Aysegul Gezer, Richard R Neubig. Neurology 2017
37
24

ADCY5 mutation carriers display pleiotropic paroxysmal day and nighttime dyskinesias.
Jennifer R Friedman, Aurélie Méneret, Dong-Hui Chen, Oriane Trouillard, Marie Vidailhet, Wendy H Raskind, Emmanuel Roze. Mov Disord 2016
34
23

Deleterious mutation in GPR88 is associated with chorea, speech delay, and learning disabilities.
Fadi Alkufri, Avraham Shaag, Bassam Abu-Libdeh, Orly Elpeleg. Neurol Genet 2016
27
29

A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia.
Raphael Carapito, Nicodème Paul, Meiggie Untrau, Marion Le Gentil, Louise Ott, Ghada Alsaleh, Pierre Jochem, Mirjana Radosavljevic, Cédric Le Caignec, Albert David,[...]. Mov Disord 2015
49
18

Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, Giorgio Bernardi, Frank S Menniti, Francesca Romana Fusco. PLoS One 2010
138
18

The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
David S Russell, Olivier Barret, Danna L Jennings, Joseph H Friedman, Gilles D Tamagnan, David Thomae, David Alagille, Thomas J Morley, Caroline Papin, Spyridon Papapetropoulos,[...]. JAMA Neurol 2014
54
18

A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations.
Silvia Esposito, Miryam Carecchio, Davide Tonduti, Veronica Saletti, Celeste Panteghini, Luisa Chiapparini, Giovanna Zorzi, Chiara Pantaleoni, Barbara Garavaglia, Dimitri Krainc,[...]. Mov Disord 2017
10
80

De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy.
Kazuyuki Nakamura, Hirofumi Kodera, Tenpei Akita, Masaaki Shiina, Mitsuhiro Kato, Hideki Hoshino, Hiroshi Terashima, Hitoshi Osaka, Shinichi Nakamura, Jun Tohyama,[...]. Am J Hum Genet 2013
122
16

Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.
Kate Baker, Sarah L Gordon, Detelina Grozeva, Margriet van Kogelenberg, Nicola Y Roberts, Michael Pike, Edward Blair, Matthew E Hurles, W Kling Chong, Torsten Baldeweg,[...]. J Clin Invest 2015
60
16

Immunohistochemical localization of PDE10A in the rat brain.
Thomas F Seeger, Brenda Bartlett, Timothy M Coskran, Jeffrey S Culp, Larry C James, David L Krull, Jerry Lanfear, Anne M Ryan, Christopher J Schmidt, Christine A Strick,[...]. Brain Res 2003
273
16

Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Heather Wilson, Flavia Niccolini, Salman Haider, Tiago Reis Marques, Gennaro Pagano, Christopher Coello, Sridhar Natesan, Shitij Kapur, Eugenii A Rabiner, Roger N Gunn,[...]. J Neurol Sci 2016
25
28

Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.
Z Xie, W O Adamowicz, W D Eldred, A B Jakowski, R J Kleiman, D G Morton, D T Stephenson, C A Strick, R D Williams, F S Menniti. Neuroscience 2006
156
16

Progressive Movement Disorder in Brothers Carrying a GNAO1 Mutation Responsive to Deep Brain Stimulation.
Neil Kulkarni, Sha Tang, Ratan Bhardwaj, Saunder Bernes, Theresa A Grebe. J Child Neurol 2016
40
15


Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.
Andrew T Bender, Joseph A Beavo. Pharmacol Rev 2006
13

Preclinical characterization of selective phosphodiesterase 10A inhibitors: a new therapeutic approach to the treatment of schizophrenia.
C J Schmidt, D S Chapin, J Cianfrogna, M L Corman, M Hajos, J F Harms, W E Hoffman, L A Lebel, S A McCarthy, F R Nelson,[...]. J Pharmacol Exp Ther 2008
230
13

Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).
K Fujishige, J Kotera, H Michibata, K Yuasa, S Takebayashi, K Okumura, K Omori. J Biol Chem 1999
320
13

Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions.
Sharron H Francis, Mitsi A Blount, Jackie D Corbin. Physiol Rev 2011
411
13

Treatment of ADCY5-Associated Dystonia, Chorea, and Hyperkinetic Disorders With Deep Brain Stimulation: A Multicenter Case Series.
Marisela E Dy, Florence C F Chang, Sol De Jesus, Irina Anselm, Neil Mahant, Pamela Zeilman, Lance H Rodan, Kelly D Foote, Wen-Hann Tan, Emad Eskandar,[...]. J Child Neurol 2016
26
23

Alternating Hemiplegia of Childhood as a New Presentation of Adenylate Cyclase 5-Mutation-Associated Disease: A Report of Two Cases.
Ana Westenberger, Christoph Max, Norbert Brüggemann, Aloysius Domingo, Karen Grütz, Heike Pawlack, Anne Weissbach, Andrea A Kühn, Juliane Spiegler, Anthony E Lang,[...]. J Pediatr 2017
17
35

Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up.
Michael Zech, Sylvia Boesch, Angela Jochim, Sandrina Weber, Tobias Meindl, Barbara Schormair, Thomas Wieland, Christian Lunetta, Valeria Sansone, Michael Messner,[...]. Mov Disord 2017
67
13

Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum.
J C Corvol, J M Studler, J S Schonn, J A Girault, D Hervé. J Neurochem 2001
148
13


Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene.
Domitille Gras, Laurence Jonard, Emmanuel Roze, Sandra Chantot-Bastaraud, Jeanette Koht, Jacques Motte, Diana Rodriguez, Malek Louha, Isabelle Caubel, Isabelle Kemlin,[...]. J Neurol Neurosurg Psychiatry 2012
67
11

Delineation of the movement disorders associated with FOXG1 mutations.
Apostolos Papandreou, Ruth B Schneider, Erika F Augustine, Joanne Ng, Kshitij Mankad, Esther Meyer, Amy McTague, Adeline Ngoh, Cheryl Hemingway, Robert Robinson,[...]. Neurology 2016
27
18

Isolation and characterization of PDE10A, a novel human 3', 5'-cyclic nucleotide phosphodiesterase.
K Loughney, P B Snyder, L Uher, G J Rosman, K Ferguson, V A Florio. Gene 1999
175
11

Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia.
Steven M Grauer, Virginia L Pulito, Rachel L Navarra, Michele P Kelly, Cody Kelley, Radka Graf, Barbara Langen, Sheree Logue, Julie Brennan, Lixin Jiang,[...]. J Pharmacol Exp Ther 2009
211
11

Phosphodiesterase 10 inhibitors: new disease modifying drugs for Parkinson's disease?
A M García, M Redondo, A Martinez, C Gil. Curr Med Chem 2014
16
31

The basal ganglia.
A M Graybiel. Curr Biol 2000
349
11




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.